Time For High Court To Clarify Presumption Of Patent Validity
Law360, New York (April 25, 2017, 5:09 PM EDT) — Charles Macedo Sandra Hudak In Microsoft Corp. v. i4i LP, 564 U.S. 91 (2011), the U.S. Supreme Court considered the role of the presumption of validity for patents, codified in 35 U.S.C. § 282. The Supreme Court’s discussion of this presumption clarified that it applies not only to validity challenges under […]
In The Press:
Law360 Reports on 2nd Circ. Says Macy’s Didn’t Infringe UK Retailer’s TM
Law360, Los Angeles (June 21, 2017, 10:14 PM EDT) — A Second Circuit panel agreed with a lower court Wednesday that Macy’s “Maison Jules” clothing line doesn’t infringe the trademark of U.K.-based clothing line Joules, saying the circuit’s eight-part trademark-confusion test weighed in the U.S. retailer’s favor. Macy’s is represented by Anthony F. LoCicero, Richard […]
In The Press:IPLaw360 reports on Petition for Certiorari filed by Charles R. Macedo and Sandra Hudak at the firm
Click here for link to article (subscription required). Click here for link to Petition
In The Press:
IPWatchdog Turns to Partner Charles R. Macedo for Insight on SCOTUS Decision Declaring Disparagement Clause of Lanham Act Unconstitutional in Matal v. Tam
Industry Reaction to SCOTUS First Amendment Decision in Matal v. Tam – http://www.ipwatchdog.com/2017/06/20/industry-reaction-scotus-first-amendment-decision-matal-v-tam/id=84791/
In The Press:
IPWATCHDOG Turns to Partner Charles R. Macedo for his Insights on SCOTUS decision in Sandoz v. Amgen over Biosimlar Drugs
Industry Reaction to SCOTUS decision in Sandoz v. Amgen By Gene Quinn Charles R. Macedo Amster Rothstein & Ebenstein LLP In Sandoz v. Amgen, the Supreme Court addressed the “plain language” of a “carefully crafted and detailed enforcement scheme” relating to “biologic” drugs. Under this complex statute that was enacted as part of ObamaCare as […]
Differing diagnoses for European and US patents. Nature Biotechnology (2017) 35(4): 334-335
Medical diagnostic patent applications in the United States and Europe face diverging fates following the Supreme Court’s decision in Mayo — See full article here
In The Press:
IPWATCHDOG turns to Partner Charles R. Macedo for his insights on the Supreme Court granting certiorari in Oil States
Industry Reaction to SCOTUS Granting Cert. in Oil States By Gene Quinn June 13, 2017 Charles R. Macedo Amster, Rothstein & Ebenstein LLP There is little doubt that the creation of Inter Partes Review (IPR) proceedings as part of the American Invents Act (AIA) — and to a lesser degree Post Grant Reviews (PGR) and […]
Patent Law Alert: In Life Technologies Corp. v. Promega Corp., U.S. Supreme Court Held That Supply of a Single Component of a Multicomponent Invention for Manufacture Abroad Does Not Give Rise to Liability for Patent Infringement Under 35 U.S.C. § 271(f)(1)
On February 22, 2017, the United States Supreme Court issued its decision in Life Technologies Corp. v. Promega Corp., unanimously reversing the United States Court of Appeals for the Federal Circuit’s decision that the supply of a single component of a multicomponent invention for manufacture abroad may trigger liability for patent infringement under 35 U.S.C. […]
In The Press:
The World’s Leading IP Strategists for 2017
Amster, Rothstein & Ebenstein LLP is pleased to announce that partner Charles R. Macedo has been named by IAM as on of its IAM Strategy 300
ARE Copyright Law Alert:Supreme Court Clarifies Standard of “Separability†for Copyright Protection for Features Incorporated into Design of Useful Article
On March 22, 2017, the Supreme Court of the United States issued its decision in Star Athletica, L.L.C. v. Varsity Brands, Inc., affirming the decision of the United States Court of Appeals for the Sixth Circuit which held that graphic designs appearing on cheerleading uniforms were copyrightable. Slip op. at 2-3. The Court provided long […]